The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...
SIMLANDI is the first high-concentration, citrate-free biosimilar to Humira that has been granted an interchangeability status by the FDA, and will qualify for interchangeable exclusivity for the 40mg ...
Vissa resultat har dolts eftersom de kan vara otillgängliga för dig.
Visa otillgängliga resultat